| Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain B Yan, S Steen, D Hambly, J Valliere-Douglass, TV Bos, S Smallwood, ... Journal of pharmaceutical sciences 98 (10), 3509-3521, 2009 | 185 | 2009 |
| Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues JF Valliere-Douglass, WA McFee, O Salas-Solano Analytical chemistry 84 (6), 2843-2849, 2012 | 171 | 2012 |
| Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer D Carter, JF Douglass, CD Cornellison, MW Retter, JC Johnson, ... Biochemistry 41 (21), 6714-6722, 2002 | 145 | 2002 |
| Mass spectrometric identification of mtb81, a novel serological marker for tuberculosis RC Hendrickson, JF Douglass, LD Reynolds, PD McNeill, D Carter, ... Journal of Clinical Microbiology 38 (6), 2354-2361, 2000 | 140 | 2000 |
| Resolving disulfide structural isoforms of IgG2 monoclonal antibodies by ion mobility mass spectrometry D Bagal, JF Valliere-Douglass, A Balland, PD Schnier Analytical chemistry 82 (16), 6751-6755, 2010 | 114 | 2010 |
| Analysis of post-translational modifications in recombinant monoclonal antibody IgG1 by reversed-phase liquid chromatography/mass spectrometry B Yan, J Valliere-Douglass, L Brady, S Steen, M Han, D Pace, S Elliott, ... Journal of Chromatography A 1164 (1-2), 153-161, 2007 | 114 | 2007 |
| Separation of populations of antibody variants by fine tuning of hydrophobic-interaction chromatography operating conditions J Valliere-Douglass, A Wallace, A Balland Journal of Chromatography A 1214 (1-2), 81-89, 2008 | 111 | 2008 |
| Glutamine-linked and non-consensus asparagine-linked oligosaccharides present in human recombinant antibodies define novel protein glycosylation motifs JF Valliere-Douglass, CM Eakin, A Wallace, RR Ketchem, W Wang, ... Journal of Biological Chemistry 285 (21), 16012-16022, 2010 | 109 | 2010 |
| Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen/deuterium exchange mass spectrometry LY Pan, O Salas-Solano, JF Valliere-Douglass Analytical chemistry 86 (5), 2657-2664, 2014 | 101 | 2014 |
| Characterization of SGN-CD123A, a potent CD123-directed antibody–drug conjugate for acute myeloid leukemia F Li, MK Sutherland, C Yu, RB Walter, L Westendorf, J Valliere-Douglass, ... Molecular cancer therapeutics 17 (2), 554-564, 2018 | 93 | 2018 |
| Measurement of in Vivo Drug Load Distribution of Cysteine-Linked Antibody–Drug Conjugates Using Microscale Liquid Chromatography Mass Spectrometry SM Hengel, R Sanderson, J Valliere-Douglass, N Nicholas, C Leiske, ... Analytical chemistry 86 (7), 3420-3425, 2014 | 81 | 2014 |
| Molecular mass analysis of antibodies by on-line SEC-MS LJ Brady, J Valliere-Douglass, T Martinez, A Balland Journal of the American Society for Mass Spectrometry 19, 502-509, 2008 | 76 | 2008 |
| Asparagine-linked oligosaccharides present on a non-consensus amino acid sequence in the CH1 domain of human antibodies JF Valliere-Douglass, P Kodama, M Mujacic, LJ Brady, W Wang, ... Journal of Biological Chemistry 284 (47), 32493-32506, 2009 | 72 | 2009 |
| Separation and characterization of an IgG2 antibody containing a cyclic imide in CDR1 of light chain by hydrophobic interaction chromatography and mass spectrometry J Valliere-Douglass, L Jones, D Shpektor, P Kodama, A Wallace, ... Analytical chemistry 80 (9), 3168-3174, 2008 | 71 | 2008 |
| Native size-exclusion chromatography-mass spectrometry: suitability for antibody–drug conjugate drug-to-antibody ratio quantitation across a range of chemotypes and drug … J Jones, L Pack, JH Hunter, JF Valliere-Douglass MAbs 12 (1), 1682895, 2020 | 52 | 2020 |
| Identification and Characterization of Putative Secreted Antigens from Babesia microti MJ Homer, MJ Lodes, LD Reynolds, Y Zhang, JF Douglass, PD McNeill, ... Journal of clinical microbiology 41 (2), 723-729, 2003 | 48 | 2003 |
| Characterization of acidic and basic variants of IgG1 therapeutic monoclonal antibodies based on non‐denaturing IEF fractionation OO Dada, N Jaya, J Valliere‐Douglass, O Salas‐Solano Electrophoresis 36 (21-22), 2695-2702, 2015 | 46 | 2015 |
| Approaches to interchain cysteine-linked ADC characterization by mass spectrometry JF Valliere-Douglass, SM Hengel, LY Pan Molecular pharmaceutics 12 (6), 1774-1783, 2015 | 45 | 2015 |
| Antibody structural integrity of site-specific antibody-drug conjugates investigated by hydrogen/deuterium exchange mass spectrometry LY Pan, O Salas-Solano, JF Valliere-Douglass Analytical chemistry 87 (11), 5669-5676, 2015 | 41 | 2015 |
| Potential Serological Use of a Recombinant Protein That Is a Replica of a Mycobacterium tuberculosis Protein Found in the Urine of Infected Mice S Mukherjee, N Daifalla, Y Zhang, J Douglass, L Brooks, T Vedvick, ... Clinical and Vaccine Immunology 11 (2), 280-286, 2004 | 40 | 2004 |
